NCT05292664 2026-03-12Venetoclax Basket Trial for High Risk Hematologic MalignanciesDana-Farber Cancer InstitutePhase 1 Recruiting30 enrolled
NCT06390319 2026-02-27Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)St. Jude Children's Research HospitalPhase 2 Recruiting100 enrolled